Insider Trading Activity Foundation Medicine, Inc. (NASDAQ:FMI) – Director Sold 4,800 shares of Stock

Insider Trading Activity For Foundation Medicine, Inc. (NASDAQ:FMI)

Story continues below

Krishna Yeshwant , Director of Foundation Medicine, Inc. (NASDAQ:FMI) reportedly Sold 4,800 shares of the company’s stock at an average price of 40.01 for a total transaction amount of $192,048.00 SEC Form

Insider Trading History For Foundation Medicine, Inc. (NASDAQ:FMI)

  • On 4/16/2014 Vincent Miller, Insider, sold 30,000 with an average share price of $26.86 per share and the total transaction amounting to $805,800.00.View SEC Filing
  • On 4/16/2014 Jason Ryan, SVP, sold 3,541 with an average share price of $26.36 per share and the total transaction amounting to $93,340.76.View SEC Filing
  • On 5/6/2014 Vincent Miller, Insider, sold 3,000 with an average share price of $30.00 per share and the total transaction amounting to $90,000.00.View SEC Filing
  • On 6/5/2014 Steven J Kafka, COO, sold 4,500 with an average share price of $24.19 per share and the total transaction amounting to $108,855.00.View SEC Filing
  • On 6/5/2014 Jason Ryan, SVP, sold 10,000 with an average share price of $24.06 per share and the total transaction amounting to $240,600.00.View SEC Filing
  • On 6/13/2014 Krishna Yeshwant, Director, sold 1,300,000 with an average share price of $22.40 per share and the total transaction amounting to $29,120,000.00.View SEC Filing
  • On 6/16/2014 Jason Ryan, SVP, sold 2,361 with an average share price of $22.61 per share and the total transaction amounting to $53,382.21.View SEC Filing
  • Analyst Ratings For Foundation Medicine, Inc. (NASDAQ:FMI)
    These are 2 Hold Ratings, 2 Buy Ratings .
    The current consensus rating for Foundation Medicine, Inc. (NASDAQ:FMI) is Buy (Score: 2.50) with a consensus target price of $35.00 , a potential (9.56% downside)

    Analyst Ratings History For Foundation Medicine, Inc. (NASDAQ:FMI)

    • On 9/16/2015 Wells Fargo & Company Downgraded rating Outperform to Market Perform
    • On 11/4/2015 Wedbush Lower Price Target of rating Neutral with a price target of $26.00 to $19.00
    • On 2/26/2016 Goldman Sachs Group, Inc. (The) Lower Price Target of rating Neutral with a price target of $17.00 to $15.00
    • On 5/4/2016 Leerink Swann Reiterated Rating Hold
    • On 8/3/2016 J P Morgan Chase & Co Reiterated Rating Hold with a price target of $25.00
    • On 11/3/2016 Benchmark Co. Downgraded rating Buy to Hold
    • On 3/7/2017 Janney Montgomery Scott Upgraded rating Sell to Neutral with a price target of $31.00

    Recent Trading Activity for Foundation Medicine, Inc. (NASDAQ:FMI)
    Shares of Foundation Medicine, Inc. closed the previous trading session at 38.70 down -0.45 -1.15% with 165,183 shares trading hands.

    An ad to help with our costs